- Breaking News
- |
- Entertainment
- |
- Sports
- |
- Business
- |
- Politics
- |
- Science
- |
- Technology
- |
- Odd News
- |
- Health
- |
- Law
New Jersey
NEW JERSEY (GaeaTimes.com)- The McNeil Consumer Healthcare unit of Johnson & Johnson has said that it is going to recall a product lot of Tylenol capsules which has affected more than 1,20,000 bottles.
BALTIMORE - A New Jersey abortion doctor accused of shuttling his patients to Maryland for late-term abortions is now accused of mistreating two additional patients, including a woman from Canada who received an abortion of a nearly full-term fetus.
NEW BRUNSWICK, N.J. - Health giant Johnson & Johnson is donating about $200 million in cash and medicine to a United Nations program aimed at improving lives of people in poor countries.
WHITEHOUSE STATION, N.J. - Drugmaker Merck & Co.
More News
- 2 abortion Drs. ordered to stop after Md. injury
- Merck foundation adds to Botswana partnership
- Manning undergoing more tests, uncertain for game
- Rutgers just says no to pot growing for NJ
- New FDA report shows multiple lapses at J&J plant
- Correction: Pfizer-Drug Failure story
- Merck hit with $8 million verdict in Fosamax trial
- Jets' Sanchez confident he'll be set for minicamp
- High hopes for business folk planning NJ pot sales
- Remains of stillborn fetus found in NJ trash truck
- Merck: Jury rules against plaintiff over Fosamax
- Bubble-blowers take aim at Guinness Book record
- Merck buys rights to potential chronic lung drug
- Merck inks deal on tetanus, diphtheria vaccine
- Jets QB Sanchez could return before training camp
- Pfizer: More Lipitor cuts heart complications more
- Merck: Study of Vytorin effectiveness to continue
- 'New' Merck has 40 drugs in mid-, late-stage tests
- J&J partner says EU rejecting skin infection drug
- Merck: Studies boost Gardasil for new uses
- Medco to buy genetic consulting company DNA Direct
- Pfizer pares, refocuses research after Wyeth buy
- NJ medical marijuana bill is signed into law
- J&J, charity to start testing artificial pancreas
- Injured Jets RB Washington ahead of rehab sked
- Concussion warnings come too late for NJ athlete
- Celgene's Revlimid meets cancer study goal
- Twisted Sister guitarist recovers from surgery
- GlaxoSmithKline pulls application for new drug use
- Ex-Kiss drummer: Breast cancer not just for women
- Emdeon 3Q loss widens on costs
- Pfizer trimming research plants after buying Wyeth
- Enzon sells specialty drug business for $300M
- Merck, now No. 2 drugmaker, set for future buys
- FDA won't accept Merck's application for new drug
